Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Fusion protein or fusion polypeptide
Reexamination Certificate
2007-07-31
2007-07-31
O'Hara, Eileen B. (Department: 1646)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Fusion protein or fusion polypeptide
C424S198100, C514S012200, C530S399000, C530S351000, C536S023500, C435S320100, C435S069500, C435S069700
Reexamination Certificate
active
10647732
ABSTRACT:
Compositions of pro-IFG-I E-peptides for the treatment and amelioration of tumor-producing diseases, and methods for their utilization.
REFERENCES:
Siegfried et al., PNAS, 89:8107-8111, Sep. 1992.
Chen Maria J. M.
Chen Thomas T.
McCarter & English LLP
O'Hara Eileen B.
University of Connecticut
LandOfFree
Anti-tumor activity of Ea-4-peptide of pro-IGF-1 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-tumor activity of Ea-4-peptide of pro-IGF-1, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-tumor activity of Ea-4-peptide of pro-IGF-1 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3740043